Safety and efficacy of a novel silver-impregnated urinary catheter system for preventing catheter-associated bacteriuria: A pilot randomized clinical trial

American Journal of Infection Control

Volumn 43, Issue 3, 2015, Pages 260-265

  Leuck, Anne Marie ^a   Johnson, James R ^a,b   Hunt, Matthew A ^a   Dhody, Kush ^c   Kazempour, Kazem ^c   Ferrieri, Patricia ^a,d   Kline, Susan ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Amarex Clinical Research   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Catheter associated bacteriuria; Foley catheter; Ionic silver; Urinary tract infection

Indexed keywords

COPPER; POLYURETHAN; SILICONE; SILVER; ANTIINFECTIVE AGENT; BIOCOMPATIBLE COATED MATERIAL;

ANTIBIOTIC THERAPY; ANTIMICROBIAL URINARY CATHETER; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACTERIURIA; CATHETER ASSOCIATED BACTERIURIA; CATHETER INFECTION; CATHETER REMOVAL; CLINICAL EFFECTIVENESS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLONY FORMING UNIT; CONTROLLED STUDY; DEVICE SAFETY; DYSURIA; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FOLEY BALLOON CATHETER; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OLIGURIA; OUTCOME ASSESSMENT; PILOT STUDY; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; SILVER IMPREGNATED URINARY CATHETER; SURGICAL PATIENT; URINARY TRACT INFECTION; URINE RETENTION; URINE VOLUME; ADOLESCENT; ADULT; AGED; BACTERIAL INFECTIONS; CATHETER-RELATED INFECTIONS; MIDDLE AGED; MYCOSES; UNIVERSITY HOSPITAL; URINARY CATHETER; URINARY TRACT INFECTIONS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CATHETER-RELATED INFECTIONS; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; MYCOSES; PILOT PROJECTS; SILVER; URINARY CATHETERS; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84923561203     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2014.11.021     Document Type: Article

References (29)

1. S. Saint, J. Wiese, J.K. Amory, M.L. Bernstein, U.D. Patel, and J.K. Zemencuk Are physicians aware of which of their patients have indwelling urinary catheters? Am J Med 109 2000 476 480
2. J.W. Weinstein, D. Mazon, E. Pantelick, P. Reagan-Cirincione, L.M. Dembry, and W.J. Hierholzer Jr. A decade of prevalence surveys in a tertiary-care center: trends in nosocomial infection rates, device utilization, and patient acuity Infect Control Hosp Epidemiol 20 1999 543 548
3. J.N. Krieger, D.L. Kaiser, and R.P. Wenzel Urinary tract etiology of bloodstream infections in hospitalized patients J Infect Dis 148 1983 57 62
4. P.A. Tambyah, and D.G. Maki Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients Arch Intern Med 160 2000 678 682
5. S. Saint Clinical and economic consequences of nosocomial catheter-related bacteriuria Am J Infect Control 28 2000 68 75
6. D.G. Maki, and P.A. Tambyah Engineering out the risk for infection with urinary catheters Emerg Infect Dis 7 2001 342 347
7. R.P. Stark, and D.G. Maki Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med 311 1984 560 564
8. Scott RD II. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention. 2009. Available from: http://www.cdc.gov/hai/pdfs/hai/scott-costpaper.pdf. Accessed December 1, 2014.
9. W.R. Jarvis Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention Infect Control Hosp Epidemiol 17 1996 552 557
10. M. Cope, M.E. Cevallos, R.M. Cadle, R.O. Darouiche, D.M. Musher, and B.W. Trautner Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital Clin Infect Dis 48 2009 1182 1188
11. B.W. Trautner Management of catheter-associated urinary tract infection Curr Opin Infect Dis 23 2010 76 82
12. S. Saint, J.A. Meddings, D. Calfee, C.P. Kowalski, and S.L. Krein Catheter-associated urinary tract infection and the Medicare rule changes Ann Intern Med 150 2009 877 884
13. E. Lo, L. Nicolle, D. Classen, K.M. Arias, K. Podgorny, and D.J. Anderson Strategies to prevent catheter-associated urinary tract infections in acute care hospitals Infect Control Hosp Epidemiol 29 Suppl 1 2008 S41 S50
14. P.A. Tambyah, K.T. Halvorson, and D.G. Maki A prospective study of pathogenesis of catheter-associated urinary tract infections Mayo Clin Proc 74 1999 131 136
15. J. Burke, and D. Riley Nosocomial urinary tract infection C.G. Mayhall, Hospital epidemiology and infection control 1996 Lippincott Williams and Wilkins Baltimore [MD] 139 153
16. W.E. Stamm Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention Am J Med 91 1991 65S 71S
17. I. Chopra The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J Antimicrob Chemother 59 2007 587 590
18. J.C. Sardi, L. Scorzoni, T. Bernardi, A.M. Fusco-Almeida, and M.J. Mendes Giannini Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options J Med Microbiol 62 2013 10 24
19. D.M. Drekonja, M.A. Kuskowski, T.J. Wilt, and J.R. Johnson Antimicrobial urinary catheters: a systematic review Expert Rev Med Devices 5 2008 495 506
20. J.R. Johnson, M.A. Kuskowski, and T.J. Wilt Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients Ann Intern Med 144 2006 116 126
21. A. Srinivasan, T. Karchmer, A. Richards, X. Song, and T.M. Perl A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections Infect Control Hosp Epidemiol 27 2006 38 43
22. R. Pickard, T. Lam, G. MacLennan, K. Starr, M. Kilonzo, and G. McPherson Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial Lancet 380 2012 1927 1935
23. J.W. Lederer, W.R. Jarvis, L. Thomas, and J. Ritter Multicenter cohort study to Assess the impact of a Silver-Alloy and hydrogel-coated urinary catheter on symptomatic catheter-associated urinary tract infections J Wound Ostomy Continence Nurs 41 2014 473 480
24. S.J. Lee, S.W. Kim, Y.H. Cho, W.S. Shin, S.E. Lee, and C.S. Kim A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters Int J Antimicrob Agents 24 Suppl 1 2004 S65 S69
25. H.L. Wald, and A.M. Kramer Feasibility of audit and feedback to reduce postoperative urinary catheter duration J Hosp Med 6 2011 183 189
26. J.R. Johnson, B. Johnston, and M.A. Kuskowski In vitro comparison of nitrofurazone- and silver alloy-coated foley catheters for contact-dependent and diffusible inhibition of urinary tract infection-associated microorganisms Antimicrobial Agents Chemother 56 2012 4969 4972
27. D.G. Maki, V. Knasinski, K. Halvorson, and P.A. Tambyah A novel silver-hydrogel impregnated indwelling catheter reduces CAUTIs: a prospective double-blind trial (abstract) Infect Control Hosp Epidemiol 19 1998 680
28. M. Ip, S.L. Lui, V.K. Poon, I. Lung, and A. Burd Antimicrobial activities of silver dressings: an in vitro comparison J Med Microbiol 55 2006 59 63
29. S.J. Eykyn Urinary tract infections in the elderly Br J Urol 82 Suppl 1 1998 79 84